“The ultra-powerful 7T scanner may help us identify those patients who we think will benefit the most. This will be important for the success of the clinical trial, and, if the drugs are effective, will mean we know which patients to give the treatment to."
Dr Rong Ye
Annovis Bio Announces First Patient Dosed in Phase 3 Trial in Patients with Early Parkinson’s Disease
Randomized Trial of Focused Ultrasound Subthalamotomy for Parkinson’s Disease
Psychiatric Treatment Crucial for Many Parkinson’s Patients
Cinnamon brings new hope for Parkinson’s Disease
Relationship between brain iron deposition and mitochondrial dysfunction in idiopathic Parkinson’s disease March 2022
